| LGORX | VMGMX | LGORX / VMGMX | |
| Total Expense Ratio | 1.21 | 0.07 | 1,729% |
| Annual Report Gross Expense Ratio | 1.40 | 0.07 | 2,000% |
| Fund Existence | 18 years | 14 years | - |
| Gain YTD | 1.251 | -2.247 | -56% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 3000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 690M | 31.9B | 2% |
| Annual Yield % from dividends | 0.00 | 0.65 | - |
| Returns for 1 year | -0.87 | 1.14 | -76% |
| Returns for 3 years | 41.27 | 37.02 | 111% |
| Returns for 5 years | -13.60 | 23.87 | -57% |
| Returns for 10 years | 60.63 | 213.77 | 28% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BTA | 9.68 | 0.08 | +0.83% |
| Blackrock Long-Term Municipal Advantage Trust | |||
| FFLV | 25.80 | 0.16 | +0.62% |
| Fidelity Fundamental Large Cap Value ETF | |||
| SPLV | 74.00 | 0.43 | +0.58% |
| Invesco S&P 500® Low Volatility ETF | |||
| DVRE | 24.03 | N/A | N/A |
| WEBs Real Estate XLRE Defined Vol ETF | |||
| BME | 41.95 | -0.20 | -0.47% |
| Blackrock Health Sciences Trust | |||